Revenue Rose, but Client Counts, Purchases and Organic Sales Fell

|15 min read
A veterinarian and two vet technicians conduct an ultrasound on a dog in an independent vet clinic exam room

Theme this week

Revenue and pet sales rose this week. Clients, patients, product purchases, organic sales and retail sales moved down. Before changing buying, staffing or forecast plans, operators should compare sales dollars with visits, invoices, product units, order history and evidence for new tools.

Executive takeaways

  1. Rising revenue does not prove more visits or purchases. Compare revenue with client, patient, invoice and product-unit counts before changing plans.
  2. OpenVet beta makes artificial intelligence (AI) rules current. Set allowed uses, prohibited data, source-review steps and veterinarian sign-off this week.
  3. Pedigree lot codes need action now. Check inventory this week, then add U.S. Food and Drug Administration (FDA) sponsor and withdrawal changes to the next product-data update.
  4. Pet-food sales need unit and price detail. Compare reported sales with organic sales, units, price, product mix and retailer stock before changing forecasts.
  5. New tools need clear evidence limits. Review MiDOG use criteria and Waltham clinic-use evidence before changing materials.

Signals

1. Clinic revenue rose while clients, patients and key purchases fell

OBSERVED

VetWatch by DVMetrics reported that year-to-date revenue growth through the week ending July 4, 2026 was up 2.7% from the same period in 2025. The revenue benchmark covered about 3,000 reporting practices. 1

VetWatch also reported weaker product purchasing through May 31, 2026. The product-purchase data covered 32,000-plus practices and shelter locations in the Animalytix Marketplace. Year-to-date purchase spending was down for core and lifestyle canine and feline vaccines, surgical-suite consumables, kennel cough vaccines, and parasiticides. Chronic-care products were up 1.9%. 1

The Fountain Briefing by Antelligence reported weaker client, invoice and patient counts for the same VetWatch week. Unique clients were down 1.7%, total invoices were down 2.3%, and unique patients were down 2.2%. 2

VIEWPOINT

Higher revenue should not by itself drive buying, staffing or growth plans. Teams need to check whether the revenue increase reflects higher prices, different services sold, more care per visit, delayed visits or fewer completed product purchases.

Review chronic-care purchases apart from vaccines and parasiticides. If chronic-care purchases hold up while vaccines or parasiticides fall, reminders, recurring orders and account plans need separate review.

Clinics and groups should compare revenue with client counts, patient counts, invoice counts and first recommended product purchases. Distributors and manufacturers should compare revenue with vaccine orders, parasiticide orders and surgical-supply orders before changing plans.

CONFIDENCE

Moderate — VetWatch and The Fountain Briefing data support the reported revenue increase and the weaker client, invoice, patient and purchase measures. The sources do not show product units, clinic-level results or enough regional detail to explain why revenue rose.

ACTIONS

Independent veterinary practices

  • Compare revenue with client, invoice, patient and product-unit counts this week.
  • Review vaccine and parasiticide reminder gaps before the next schedule review.

Corporate veterinary groups and clinic consolidators

  • Standardize weekly reporting for revenue, clients, invoices, patients and product units within 30 days.
  • Flag clinics where revenue rises while patient or product-unit counts fall this month.

Distributors, e-retail and home delivery providers

  • Compare vaccine and parasiticide order units with last year this month.
  • Review recurring vaccine and parasiticide order gaps from the last 60 days this month.

Manufacturers and commercial operators

  • Separate price changes, product mix and unit counts in July account reviews.
  • Prepare account questions on vaccine, parasiticide and surgical-supply orders this month.

↑ Back to top

2. OpenVet beta means clinics need artificial intelligence rules

OBSERVED

OpenVet announced on June 30, 2026, that licensed veterinarians can use its product free in public beta. The company said veterinarians can use the tool through the app or by email. 3

OpenVet said users can email a clinical question or forward a blood-test result. Users then receive a structured answer with possible causes, dosing, next steps, source links, calculators and follow-up questions. 3

OpenVet said clinical claims link to sources and that the veterinarian remains the decision-maker. The company said records are encrypted and are not used to train outside models. 3

VIN News reported on July 2, 2026, that UK veterinary artificial intelligence (AI) transparency principles were being finalized. VIN also reported that American Veterinary Medical Association (AVMA) guidance in the US remained under development. VIN described rule areas that include validation, data handling, transparency, consent, documentation, human oversight and practice-level checks. 4

VIEWPOINT

Free public beta access makes informal AI use easier inside clinics. Clinics should set rules before use varies by case, doctor or team member.

The rules should cover who may use the tool and what data may be entered. They should also cover source review, documentation, veterinarian sign-off and escalation.

Vendors and manufacturers should prepare for questions about sources, data handling and medicine-list or formulary references.

CONFIDENCE

Moderate — OpenVet’s release supports beta availability and company-stated features. VIN reporting supports the need for clinic AI rules. The reviewed sources do not show independent test results for OpenVet’s clinical accuracy, safety or reliability.

ACTIONS

Independent veterinary practices

  • Draft clinic rules for allowed AI uses and prohibited data this week.
  • Add source-review and veterinarian sign-off steps this week.

Corporate veterinary groups and clinic consolidators

  • Assign medical and technology owners for AI rules within 30 days.
  • Build a vendor checklist for data use, validation, consent and documentation within 30 days.

Distributors, e-retail and home delivery providers

  • Track clinic pharmacy questions that cite AI tools this month.
  • Set escalation steps for AI-generated medicine or formulary questions this month.

Manufacturers and commercial operators

  • Review evidence files for priority products that AI tools may cite this month.
  • Prepare source, label and safety citations for priority products this month.

↑ Back to top

3. FDA rule and Pedigree recall call for product-record checks

OBSERVED

FDA published a Federal Register rule on July 7, 2026. The rule was effective the same day. It updated animal-drug regulations for approvals, abbreviated applications, conditional approvals, withdrawals and sponsor changes from January through March 2026. 5

The rule includes companion animal entries such as potassium bromide chewables and maropitant chewables. It also includes Bravecto Plus, NexGard Plus and Bravecto Quantum. 5

FDA also posted Mars Petcare US’s July 2, 2026, voluntary recall of two Pedigree wet dog food lots. The affected product was Pedigree Can High Protein Chopped Chicken and Duck Flavor 13.2 oz wet dog food. 6

The FDA-posted announcement said the product had been sent to a third-party vendor for destruction. It also said the product appeared to have been fraudulently diverted and sold in the US. The announcement said the product may contain metal and plastic foreign material. The affected lot codes are 613C3KKCFC and 613C1KKCFC. 6

VIEWPOINT

Both items point to a need for product-record checks, but the timing differs. The Pedigree recall needs an immediate lot-code and inventory check. The FDA rule should be added to the next product-data, medicine-list or formulary update.

Clinics and groups should check inventory, client-service wording and affected medicine lists. Distributors and e-retailers should check inventory, order history and customer-service wording. Manufacturers should check sponsor names, withdrawal records and customer-facing product data.

Small record errors can create extra work. If a team misses a sponsor-name change, withdrawal record, product name or lot code, staff may spend more time correcting records and answering client questions.

CONFIDENCE

High — Federal Register and FDA-posted recall records support the facts. How much work this creates depends on each operator’s inventory, order history, product records and client-service volume.

ACTIONS

Independent veterinary practices

  • Check affected Pedigree lot codes in clinic inventory this week.
  • Update client-service wording for Pedigree recall questions before Monday.

Corporate veterinary groups and clinic consolidators

  • Send one product-record update process to all clinics within 30 days.
  • Assign recall-check owners for inventory, purchasing and client service this week.

Distributors, e-retail and home delivery providers

  • Search affected Pedigree lot codes in inventory and order history this week.
  • Update customer-service wording for affected-order questions before the next fulfillment run.

Manufacturers and commercial operators

  • Review sponsor-name and withdrawal records before the next product-data update.
  • Check customer-facing product data against FDA and recall records this month.

↑ Back to top

4. General Mills pet sales rose while organic sales fell

OBSERVED

General Mills reported North America Pet fourth-quarter fiscal 2026 net sales of $702 million, up 4%. The company said an extra fiscal week added 7 percentage points to the quarter. 7

The same release showed organic and retail sales moved down. Organic net sales fell 3%, and retail sales across all channels fell about 1%. 7

For the full fiscal year, North America Pet net sales rose 6% to $2.6 billion. General Mills said the Whitebridge Pet Brands acquisition added 6 percentage points. The extra fiscal week added 2 percentage points. Full-year organic net sales fell 3%. 7

VIEWPOINT

The reported sales increase does not prove that shoppers bought more pet food. Acquisition and calendar effects helped the result, while organic sales and retail sales moved down.

Distributors, e-retailers, home-delivery providers and manufacturers should check units, price, product mix, retailer stock levels and shipment timing before changing forecasts. Clinics should apply the same check only to clinic-dispensed diets, where they can compare diet revenue with units sold and reorders.

CONFIDENCE

High — General Mills’ earnings release supports the sales figures. The figures do not prove that shoppers bought more pet food, because reported growth includes the Whitebridge acquisition, an extra fiscal week and retailer stock changes.

ACTIONS

Independent veterinary practices

  • Compare diet revenue with diet units sold this month.
  • List clinic-dispensed diets with lower reorders this month.

Corporate veterinary groups and clinic consolidators

  • Compare nutrition revenue, units sold and margin across clinics this quarter.
  • Identify clinics where diet revenue rose but units fell this quarter.

Distributors, e-retail and home delivery providers

  • Compare pet-food shipments with sales data before the next forecast update.
  • Check whether July orders reflect retailer stock changes this month.

Manufacturers and commercial operators

  • Compare reported sales with organic sales before account reviews this month.
  • Prepare account questions on units, price, product mix and retailer stock this month.

↑ Back to top

5. MiDOG launches parasite-only test for unresolved parasite questions

OBSERVED

MiDOG Animal Diagnostics announced MiDOG Parasite-Only Testing on July 1, 2026. MiDOG said the test uses next-generation sequencing (NGS). NGS looks for genetic material in a sample to help identify organisms. 8

MiDOG said its reference database includes more than 4,300 parasite and protozoan reference genomes. The company said results are typically available within 48 hours. 8

MiDOG’s product page says the test is for cases where parasite detection is the main question. The page lists persistent gastrointestinal signs, unexplained diarrhea and unclear exposure history as examples. It also lists rescue, shelter, imported, exotic, zoo, aquarium and wildlife cases. 9

VIEWPOINT

Practices need to decide when to consider this test for unresolved parasite questions. Case criteria should stay tied to the source examples, such as persistent gastrointestinal signs, unclear exposure history, rescue or shelter cases, imported animals and exotic animals.

Clinics and groups should set sample and result-review steps before use grows. Manufacturers and diagnostic operators should track account questions about parasite sequencing tests, especially in shelter, imported-animal, exotic-animal and wildlife cases.

CONFIDENCE

Moderate — MiDOG’s release and product page support the launch, test details and listed case types. The reviewed sources do not show clinic adoption, client payment behavior, or how easily clinics can collect samples, ship them and review results.

ACTIONS

Independent veterinary practices

  • Decide when staff should raise unresolved parasite cases for veterinarian review this month.
  • Assign one staff owner for sample collection and shipping this month.

Corporate veterinary groups and clinic consolidators

  • Update parasite-testing guidance with case criteria within 30 days.
  • Track test use by case type and result-review owner this month.

Distributors, e-retail and home delivery providers

  • List clinic account questions about sample submission and shipping this month.
  • Confirm veterinarian-submission requirements before creating support materials this month.

Manufacturers and commercial operators

  • Review parasite-test claim wording before field use this month.
  • Track account questions about complex parasite testing this quarter.

↑ Back to top

Early watch item

1. Waltham FelQoL may add home-behavior questions to feline visits

OBSERVED

Waltham Petcare Science Institute said it developed and validated a feline quality-of-life tool with Mars Veterinary Health, Royal Canin and the University of Bristol. Waltham said FelQoL is being used to understand cat wellbeing through the Mars Petcare Biobank. 12

The Part 1 Journal of Feline Medicine and Surgery paper used responses from 1,324 cat owners in the U.S. and U.K. It identified seven quality-of-life dimensions called Active, Talkative, Satisfied, Relaxed, Mobile, Appetite and Sociable. The paper said the questionnaire can help veterinary professionals gather information that complements in-clinic health assessments. 13

The Part 2 paper used the same owner-response base to assess how demographics, health and environment affect FelQoL scores. It said FelQoL may help cat owners track quality of life at home. It also said the tool may support more intentional veterinary consultations when wellbeing declines without obvious illness or injury. 14

SPECULATIVE ASSESSMENT

FelQoL could become useful to operators if clinics add the questionnaire to feline wellness forms, chronic-care reviews, quality-of-life check-ins or nutrition discussions. Current evidence supports the questionnaire and its use in research and the Mars Petcare Biobank. Routine clinic use has not been shown.

Published clinic forms, staff training, client score reports or follow-up rules would matter most. For now, operators should track whether the questionnaire moves from research use into clinic forms or client materials.

CONFIDENCE

Moderate — the Waltham page and two journal papers support the questionnaire, owner-response base and seven dimensions. The reviewed sources do not show routine clinic use, client score reports or operator workflows.

WHAT WOULD CONFIRM THIS

  • Published use of FelQoL questions in feline wellness or chronic-care visits.
  • Banfield, Mars Veterinary Health or Royal Canin adds FelQoL to clinic forms or client tools.
  • Client score reports or nutrition-support materials use FelQoL results.
  • Follow-up timing changes when FelQoL scores decline over time.

WHAT WOULD RULE THIS OUT

  • FelQoL remains limited to research or Mars Petcare Biobank use.
  • No clinic forms, staff training or client reports appear.
  • Veterinarians or cat owners rarely complete the questionnaire.
  • Scores are not used in follow-up timing, client discussion or nutrition-support materials.

HOW TO PREPARE NOW

Independent veterinary practices

  • Review feline visit forms for activity, appetite, mobility and social-behavior questions this month.
  • List client questions about cat behavior changes during wellness visits this month.

Corporate veterinary groups and clinic consolidators

  • Compare feline wellness templates for home-behavior questions across clinics this quarter.
  • Track published FelQoL forms or client materials from Banfield, Mars Veterinary Health and Royal Canin this quarter.

Distributors, e-retail and home delivery providers

  • Record account questions about FelQoL-linked nutrition or home-monitoring offers this quarter.
  • List support materials needed if client score reports or clinic tools appear this quarter.

Manufacturers and commercial operators

  • Track whether nutrition materials mention FelQoL scores this quarter.
  • Prepare evidence questions before using feline quality-of-life claims this month.

↑ Back to top

Methodology and Governance

This PULSE Edition covers developments posted or acted on from July 1 through July 8, 2026, using U.S. Eastern Time.

Observed statements are anchored to public sources and attributed subscriber reports cited below. Viewpoints are PETMETRIX assessments that interpret commercial implications for operators. Early watch items are early hypotheses. They are not yet strong enough for a full Signal, and they include what would confirm or rule out the pattern.

PETMETRIX PULSE commercial intelligence is provided for informational use and to support lawful, independent business decisions. It is not legal, clinical, reimbursement, accounting, or financial advice. Route legal, clinical, reimbursement, accounting, and financial decisions to qualified advisers. Respect for the veterinary-client-patient relationship is mandatory.

Terms of Service | Privacy Policy | Methodology and Data Disclaimer

Glossary

Artificial intelligence (AI): Software that performs tasks that usually require human reasoning, such as summarizing records, answering questions, finding patterns, or drafting text.

Public beta: A test release that a company makes available to users before the product is in final general release.

Product record: A record of product details such as product name, sponsor, approval status, lot code, recall status, and customer-facing information.

Lot code: A manufacturer code used to identify a specific batch or production run, often for inventory checks and recalls.

Sponsor change: A change to the sponsor listed in a regulatory record as responsible for an animal drug application or product.

Formulary: A list of medicines or products that a clinic, group, insurer, or other operator allows, stocks, recommends, or covers.

Organic net sales: A sales measure that removes items such as acquisitions, divestitures, currency changes, and other company-defined adjustments.

Retail sales across all channels: Retail sales across stores, online channels, and other retail paths included in a company’s reporting.

Clinic-dispensed diets: Pet diets sold or supplied through a veterinary clinic, including therapeutic diets and other clinic-recommended diets.

Next-generation sequencing (NGS): A lab method that reads many genetic sequences in a sample to help identify organisms or genetic material.

Reference genome: A genetic sequence stored in a database and used as a comparison point when identifying organisms in samples.

Parasite-only testing: A test panel focused on detecting parasites and protozoa, rather than a broad test for many organism types.

Feline Quality of Life (FelQoL): A questionnaire designed to assess a cat’s emotional and physical wellbeing from owner observations.

Mars Petcare Biobank: A Mars Petcare research program that collects pet health data and biological samples to study animal health and wellbeing.

References

  1. Animalytix. “Vet Watch® Insight Report Week 26 - June 2026.” July 7, 2026. Subscriber email received by PETMETRIX July 7, 2026. https://www.vetwatch.com
  2. Antelligence Corp. “PE ownership of vet clinics draws scrutiny of PBS News Hour.” The Fountain Briefing. July 7, 2026. Subscriber email received by PETMETRIX received July 7, 2026. https://www.antelligence.com/the-fountain-report/
  3. OpenVet. “OpenVet Opens to Every Licensed Veterinarian, Free.” June 30, 2026. https://openvet.ai
  4. VIN News. “AI guardrails emerge as veterinarians mull ethics, safety risks.” July 2, 2026. https://news.vin.com/doc/?id=13372087
  5. U.S. Food and Drug Administration. “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor.” July 7, 2026. https://www.federalregister.gov/documents/2026/07/07/2026-13716/new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-new-animal-drug
  6. U.S. Food and Drug Administration / Mars Petcare US. “Voluntary Recall of Two Lots of PEDIGREE® Can High Protein Chopped Chicken & Duck Flavor Wet Dog Food Due to Potential Fraudulent Distribution of Product Which May Contain Foreign Material.” July 2, 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-recall-two-lots-pedigreer-can-high-protein-chopped-chicken-duck-flavor-wet-dog-food-due
  7. General Mills. “General Mills Reports Fiscal 2026 Fourth-quarter Adjusted Results in Line with Company Expectations.” July 1, 2026. https://www.generalmills.com/news/press-releases/general-mills-reports-fiscal-2026-fourth-quarter-adjusted-results-in-line-with-company-expectations
  8. MiDOG Animal Diagnostics. “MiDOG Animal Diagnostics Launches First Dedicated NGS-Based Parasite Detection Test for Veterinary Medicine.” July 1, 2026. https://www.prnewswire.com/news-releases/midog-animal-diagnostics-launches-first-dedicated-ngs-based-parasite-detection-test-for-veterinary-medicine-302815298.html
  9. MiDOG Animal Diagnostics. “MiDOG Parasite-Only Testing: A Focused Way to Look Deeper for Parasites.” Accessed July 8, 2026. https://www.midogtest.com/midog-parasite-only-testing/
  10. Akston Biosciences. “Akston’s NGF-Targeting Ambifect® Candidates Demonstrate Clinically Meaningful Osteoarthritis Pain and Function Improvements Comparable to Bedinvetmab in Head-to-Head Canine Study.” July 7, 2026. https://www.prnewswire.com/news-releases/akstons-ngf-targeting-ambifect-candidates-demonstrate-clinically-meaningful-osteoarthritis-pain-and-function-improvements-comparable-to-bedinvetmab-in-head-to-head-canine-study-302819322.html
  11. Frontiers in Veterinary Science. “Application of NMR-based metabolomics and machine learning for non-invasive disease screening in dogs.” June 30, 2026. https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1830153/full
  12. Waltham Petcare Science Institute. “Feline Quality of Life study.” No visible publication date on website page, accessed July 8, 2026. https://www.waltham.com/feline-quality-life-study
  13. Journal of Feline Medicine and Surgery. Albergante et al. “A new generic feline quality of life (FelQoL) questionnaire: part 1 – development and validation.” 2026. https://journals.sagepub.com/doi/10.1177/1098612X261448700
  14. Journal of Feline Medicine and Surgery. Albergante et al. “A new generic feline quality of life (FelQoL) questionnaire: part 2 – initial evaluation of clinical utility.” 2026. https://journals.sagepub.com/doi/10.1177/1098612X261447559
↑ Back to top